Portfolio company
Single molecule diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BillionToOne
This company develops molecular diagnostic tests for prenatal screening and oncology care to help clinicians and patients identify genetic conditions and monitor cancer.
Singular Bio
The company develops single molecule detection technology for cell-free DNA analysis to provide non-invasive prenatal screening for the healthcare and genomics sectors.
Molecular Stethoscope
This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.
Oncoliq
This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Predicta Biosciences
This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.
SimSen Diagnostics
This company develops ultra-sensitive liquid biopsy tests to detect and monitor circulating tumour DNA for healthcare providers, research hospitals and pharmaceutical companies.
